Drugs / LGvax
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03338777 | Feb 2020 | melanoma | Hospital Italiano de Buenos Aires | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LGvax | “subcutaneous injections of a vaccine (LGvax) produced with formolized extracts of allogeneic melanoma” NCT03338777 ↗ |
| Modality | Vaccine | “a vaccine (LGvax)” NCT03338777 ↗ |
| Route | Subcutaneous | “subcutaneous injections of a vaccine” NCT03338777 ↗ |